Danone is expanding into GLP-1 nutrition with dairy, microbiome solutions, and plant-based shakes. Three key moves shaping ...

"Product puzzle: food makers weigh up rise of GLP-1 drugs" was originally created and published by Just Food, a GlobalData owned brand.

Danone's Irini Schoeman-Giziakis joins AgFunderNews to talk open innovation, nutrition in the GLP-1 era, and artificial ...

Danone has launched a drinkable yogurt product under its Oikos brand in the US targeted at users of the Ozempic and other GLP-1 weight-loss drugs. The product, called Oikos Fusion, is designed to help ...

GLP-1 drugs are a class of medication used to treat type 2 diabetes and obesity. While they are generally safe to use, they can cause side effects, such as nausea, vomiting, and diarrhea. Starting on ...

The Oikos and Activia maker said supply constraints have forced the company to make “trade-offs” within its innovation strategy.

Danone is struggling to meet demand for high-protein yogurt while coffee creamers continue to be a drag on performance in ...

Danone's high-performing Chinese business drove a third-quarter sales beat on Tuesday, with strong demand in China for infant ...

July 1st, 2025: Danone successfully completed the acquisition of a majority stake in Kate Farms, a fast-growing U.S. business and the #1 doctor-recommended plant-based brand in the U.S.2, offering a ...